盆腔淋巴结切除数目作为FIGO IB1期宫颈癌淋巴结阴性患者的预后标志物
回顾性队列研究纳入782例FIGO IB1期宫颈癌患者,均行腹腔镜根治性子宫切除术及统一盆腔淋巴结切除术,中位随访64.7个月。多因素分析显示盆腔淋巴结切除数目是PFS和CSS的独立预后因素,在淋巴结阴性患者中切除≤10枚者进展风险为>10枚者的5.550倍、死亡风险为5.596倍。
要点
- 盆腔淋巴结切除数目是IB1期宫颈癌PFS和CSS的独立预后因素。
- 淋巴结阴性患者中切除≤10枚者进展风险为>10枚者的5.550倍。
- 淋巴结阴性患者中切除≤10枚者死亡风险为>10枚者的5.596倍。
核心结论
- 在统一盆腔淋巴结切除术的前提下,盆腔淋巴结切除总数可能是无淋巴结转移的IB1期宫颈癌患者至少5年随访结局的有价值预测指标。
研究设计与样本
- 回顾性队列研究,纳入782例IB1期宫颈癌患者,来自复旦大学附属妇产科医院。
- 干预为腹腔镜根治性子宫切除术及统一盆腔淋巴结切除术(髂总、髂外、髂内、闭孔)。
- 中位随访时间64.7个月(范围4.3-102.8个月)。
主要发现
- 782例患者中位盆腔淋巴结切除数为19枚(范围7-49枚)。
- 切除≤10枚者21例(2.7%),11-20枚者461例(59.0%),21-30枚者263例(33.6%),≥31枚者37例(4.7%)。
- 4组间临床病理特征差异无统计学意义(p>.05)。
- 多因素分析显示盆腔淋巴结切除数目是PFS(p=.015)和CSS(p=.029)的独立预后因素。
- 按淋巴结转移分层后,在盆腔淋巴结阴性患者中淋巴结切除数目仍是独立预测因素(CSS p=.026,PFS p=.012)。
关键数值与推荐
- 无淋巴结转移患者中,淋巴结切除数目≤10枚者进展风险为>10枚者的5.550倍(p<.001)。
- 无淋巴结转移患者中,淋巴结切除数目≤10枚者死亡可能性为>10枚者的5.596倍(p=.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To investigate whether the number of removed lymph nodes (RLNs) influences the clinical outcome of stage IB1 cervical cancer on the premise of uniform pelvic lymphadenectomy. DESIGN: Retrospective cohort study. SETTING: Obstetrics and Gynecology Hospital of Fudan University. PATIENTS: Women (n = 782) with stage IB1 cervical cancer. INTERVENTIONS: Laparoscopic radical hysterectomy and uniform pelvic lymphadenectomy (common iliac, external iliac, internal iliac, obturator) for stage IB1 cervical cancer. The median time of follow-up was 64.7 months (range, 4.3-102.8). MEASUREMENTS AND MAIN RESULTS: Of 782 patients with stage IB1 cervical cancer, the median number of pelvic RLNs was 19 (range, 7-49). Twenty-one patients (2.7%) had RLNs ≤ 10, 461 (59.0%) had 11 to 20, 263 (33.6%) had 21 to 30, and 37 (4.7%) had RLNs ≥ 31. The differences were not statistically significant in the clinicopathologic characteristics between the 4 groups (p >.05). In the multivariate analysis, pelvic RLN number became an independent prognostic factor for progression-free survival (PFS) and cancer-specific survival (CSS) in stage IB1 cervical cancer (p = .029; .015 for CSS and PFS). After the stratified analysis by lymph node metastasis, RLN number remained an independent predictive value (p = .026 for CSS, p = .012 for PFS) in patients with negative pelvic lymph nodes. Moreover, patients with RLN number ≤ 10 carried a 5.550-fold higher risk for progression (p <.001) and 5.596-fold greater likelihood of death (p = .001) than those with RLN number > 10 in case of no lymph node metastasis. CONCLUSION: With uniform pelvic lymphadenectomy, the total pelvic RLN number could be a valuable predictor of outcome in stage IB1 cervical cancer without lymph node metastasis during a follow-up of at least 5 years.
引用
- Wang R, Tao X, Wu X, et al. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes. J Minim Invasive Gynecol. 2019. PMID: 31394263. doi:10.1016/j.jmig.2019.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。